Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection

The Journal of Experimental Medicine
Andrew D HislopAlan B Rickinson

Abstract

Primary virus infection often elicits a large CD8(+) T cell response which subsequently contracts to a smaller memory T cell pool; the relationship between these two virus-specific populations is not well understood. Here we follow the human CD8(+) T cell response to Epstein-Barr virus (EBV) from its primary phase in infectious mononucleosis (IM) through to the persistent carrier state. Using HLA-A2.1 or B8 tetramers specific for four lytic cycle and three latent cycle epitopes, we find marked differences in the epitope-specific composition of the T cell populations between the two phases of infection. The primary response is dominated by lytic epitope specificities which are severely culled (and in one case extinguished) with resolution of the acute infection; in contrast latent epitope specificities are less abundant, if present at all, in acute IM but often then increase their percentage representation in the CD8 pool. Even comparing epitopes of the same type, the relative size of responses seen in primary infection does not necessarily correlate with that seen in the longer term. We also follow the evolution of phenotypic change in these populations and show that, from a uniform CD45RA(-)RO(+)CCR7(-) phenotype in IM, lytic ...Continue Reading

References

Jan 1, 1990·The Journal of Experimental Medicine·S R BurrowsD J Moss
May 10, 1984·The New England Journal of Medicine·J W SixbeyJ S Pagano
Sep 1, 1994·The Journal of General Virology·S R BurrowsA Suhrbier
Oct 4, 1996·Science·J D AltmanM M Davis
Nov 1, 1996·The Journal of Experimental Medicine·E ScotetE Houssaint
Aug 1, 1997·Journal of Virology·M F BachmannP S Ohashi
Sep 18, 1997·The Journal of Experimental Medicine·A LalvaniA J McMichael
Jan 28, 1998·Journal of Virology·P G Stevenson, P C Doherty
Jul 7, 1998·The Journal of Experimental Medicine·D H BuschE G Pamer
Dec 17, 1998·Journal of Clinical Microbiology·H KimuraT Morishima
Feb 17, 1999·The Journal of Experimental Medicine·D H Busch, E G Pamer
Dec 2, 1999·Nature·A W Goldrath, M J Bevan
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M GraysonR Ahmed
May 3, 2000·The Journal of Experimental Medicine·F LechnerB D Walker
Oct 18, 2000·Proceedings of the National Academy of Sciences of the United States of America·G J Babcock, D A Thorley-Lawson
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·N E AnnelsA B Rickinson
Nov 22, 2000·The Journal of Clinical Investigation·M F CallanA J McMichael
Nov 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J N BlattmanJ D Altman
Jan 10, 2001·The Journal of Experimental Medicine·P J GoulderC Brander
May 26, 2001·The Journal of Clinical Investigation·R KaulS L Rowland-Jones
Aug 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A D HislopA B Rickinson
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S J TurnerP C Doherty
Oct 10, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M D CatalinaK Luzuriaga

❮ Previous
Next ❯

Citations

Sep 13, 2006·Springer Seminars in Immunopathology·Rabih HalwaniRafick-Pierre Sékaly
Mar 16, 2005·Current Opinion in Immunology·Willem W Overwijk
Nov 25, 2003·Human Immunology·Bing ZhaoPandjassarame Kangueane
Dec 5, 2002·Trends in Immunology·Debbie van BaarleFrank Miedema
Feb 9, 2011·Immunology and Cell Biology·Scott R BurrowsRajiv Khanna
Oct 29, 2004·Nature Reviews. Cancer·Lawrence S Young, Alan B Rickinson
Mar 24, 2004·Nature Reviews. Microbiology·Matthias G von HerrathJ Lindsay Whitton
Jun 24, 2005·The New England Journal of Medicine·Bart KeymeulenLucienne Chatenoud
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Noémi NagyEva Klein
Sep 17, 2003·The Journal of Experimental Medicine·Elisabeth AmyesMargaret F C Callan
Apr 7, 2004·The Journal of Experimental Medicine·Rika DraenertPhilip J R Goulder
Dec 22, 2004·The Journal of Experimental Medicine·Stanley R Riddell
May 31, 2007·The Journal of Experimental Medicine·Melissa L PrecopioRichard A Koup
May 18, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nicola E AnnelsArjan C Lankester
Oct 11, 2005·Viral Immunology·Philip G Stevenson, Stacey Efstathiou
Jun 18, 2004·Current Opinion in Rheumatology·Margaret F C Callan
Nov 23, 2007·Journal of Virology·Suzanne L ElliottMandvi Bharadwaj
Sep 6, 2005·Journal of Virology·Oscar NorbeckThomas Tolfvenstam
Mar 23, 2004·Annual Review of Immunology·Raymond M WelshEva Szomolanyi-Tsuda
Mar 23, 2004·Annual Review of Immunology·Federica SallustoAntonio Lanzavecchia
Mar 24, 2007·Annual Review of Immunology·Andrew D HislopAlan B Rickinson
Jan 1, 2010·Advances in Virology·Rebecca C RobeyFrances M Gotch
Mar 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emanuela RomanoJames W Young
Aug 20, 2005·The Journal of Clinical Investigation·Andrew D HislopAlan B Rickinson
Nov 21, 2007·Hematology·Richard F Ambinder

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
FACS

Software Mentioned

SAS

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.